Published in Crit Care on December 17, 2012
Variation in the BDNF gene interacts with age to predict mortality in a prospective, longitudinal cohort with severe TBI. Neurorehabil Neural Repair (2014) 0.84
Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships Between Genetics and Acute Systemic and Central Nervous System BDNF Profiles. Neurorehabil Neural Repair (2015) 0.82
The Association of Serum Levels of Brain-Derived Neurotrophic Factor with the Occurrence of and Recovery from Delirium in Older Medical Inpatients. Biomed Res Int (2017) 0.75
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med (1999) 7.24
Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med (2001) 7.14
Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med (2011) 2.97
Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov (2011) 2.65
Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev (2012) 2.54
Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet (2004) 2.52
Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett (2002) 2.51
The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging (2005) 2.39
Increased levels of serum S100B protein in critically ill patients without brain injury. Shock (2006) 2.21
Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost (2002) 2.16
Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res (1996) 2.12
Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med (2006) 2.01
Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke (2008) 1.38
Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord (2007) 1.38
Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37
Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One (2010) 1.32
GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology (2012) 1.29
Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med (2010) 1.12
Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J Clin Psychiatry (2011) 1.11
Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem (2010) 1.10
Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res (2010) 1.10
S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment. Resuscitation (2010) 1.09
Sustained expression of brain-derived neurotrophic factor is required for maintenance of dendritic spines and normal behavior. Neuroscience (2012) 1.04
Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intensive Care Med (2003) 0.98
Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care (2010) 0.96
Brain Derived Neurotrophic Factor: a novel neurotrophin involved in psychiatric and neurological disorders. Pharmacol Ther (2012) 0.95
Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One (2010) 0.95
Spatially restricted actions of BDNF. Neuron (2002) 0.85
Effects of voluntary running on plasma levels of neurotrophins, hippocampal cell proliferation and learning and memory in stressed rats. Neuroscience (2012) 0.83
Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology (2000) 0.82
Plasma brain-derived neurotrophic factor levels are associated with clinical severity in school age children with asthma. Clin Exp Allergy (2010) 0.79
Lack of association of S100β and neuron-specific enolase with mortality in critically ill patients. Rev Bras Psiquiatr (2013) 0.77
Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med (2005) 2.25
Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med (2003) 1.93
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med (2004) 1.74
Mitochondrial dysfunction and psychiatric disorders. Neurochem Res (2008) 1.73
Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury. Nephrol Dial Transplant (2012) 1.68
Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med (2008) 1.65
Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med (2005) 1.63
Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med (2006) 1.57
Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit Care Med (2004) 1.54
Delirium recognition and sedation practices in critically ill patients: a survey on the attitudes of 1015 Brazilian critical care physicians. J Crit Care (2009) 1.54
Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med (2007) 1.50
Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania. J Psychopharmacol (2012) 1.44
Early sedation and clinical outcomes of mechanically ventilated patients: a prospective multicenter cohort study. Crit Care (2014) 1.44
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology (2011) 1.41
The Pietà study: epidemiological investigation on successful brain aging in Caeté (MG), Brazil. Methods and baseline cohort characteristics. Arq Neuropsiquiatr (2011) 1.40
The validity and reliability of the Portuguese versions of three tools used to diagnose delirium in critically ill patients. Clinics (Sao Paulo) (2011) 1.33
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.28
Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res (2011) 1.24
The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol (2007) 1.19
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18
Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int (2009) 1.13
Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med (2011) 1.13
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry (2010) 1.12
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci (2006) 1.11
Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10
Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res (2010) 1.10
The role of free radicals in sepsis development. Front Biosci (Elite Ed) (2009) 1.10
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci (2006) 1.08
Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Neuroscience (2007) 1.07
Comparison of CAM-ICU and ICDSC for the detection of delirium in critically ill patients focusing on relevant clinical outcomes. J Crit Care (2011) 1.05
Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion (2008) 1.04
Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.04
Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Crit Care Med (2006) 1.04
Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J Obstet Gynaecol Res (2008) 1.03
Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress. J Surg Res (2009) 1.02
Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int (2008) 1.02
Imbalance in SOD/CAT activities in rat skeletal muscles submitted to treadmill training exercise. Cell Biol Int (2006) 0.99
Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett (2008) 0.99
Inflammation biomarkers and delirium in critically ill patients. Crit Care (2014) 0.98
Il1-β involvement in cognitive impairment after sepsis. Mol Neurobiol (2013) 0.97
Skeletal muscle electron transport chain dysfunction after sepsis in rats. J Surg Res (2011) 0.97
Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatr Res (2008) 0.97
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol (2012) 0.97
Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium. J Gastroenterol Hepatol (2007) 0.96
Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care (2010) 0.96
Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev (2010) 0.95
Oxidative parameters differences during non-lethal and lethal sepsis development. J Surg Res (2005) 0.95
Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord (2006) 0.94
Functional performance and inflammatory cytokines after squat exercises and whole-body vibration in elderly individuals with knee osteoarthritis. Arch Phys Med Rehabil (2012) 0.94
Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice. J Neuroinflammation (2011) 0.94
Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.94
Serum heat shock protein 70 levels, oxidant status, and mortality in sepsis. Shock (2011) 0.94
Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease. Neuromolecular Med (2012) 0.93
Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats. Crit Care (2008) 0.93
Long-term cognitive impairment in sepsis survivors. Crit Care Med (2005) 0.93
Antipsychotic-induced oxidative stress in rat brain. Neurotox Res (2008) 0.93